About the Company
We do not have any company description for Cyclerion Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CYCN News
Cyclerion Therapeutics Inc Ordinary Shares CYCN
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Cyclerion Therapeutics (NASDAQ: CYCN)
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes ...
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023
Cyclerion Therapeutics (NASDAQ:CYCN) just reported results for the fourth quarter of 2023. Cyclerion Therapeutics reported earnings per share of -$1.60. The company did not report any revenue for ...
12 Best Biotech Penny Stocks to Invest In
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) is a Boston-based biopharma firm founded in 2018. Cyclerion Therapeutics, Inc.
DiaMedica Therapeutics Inc. (DMAC)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
FULC Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high ...
Cyclerion Therapeutics Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...